Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to evaluate the efficacy and safety of XAV-19 drug in patients with moderate-to-severe COVID-19.
Epistemonikos ID: 0d52d880fb0d1b53a556b4b222202384ff029800
First added on: Jun 17, 2021